author_facet Zhang, Tian
Guan, Xu-Wen
Gribben, John G.
Liu, Feng-Ting
Jia, Li
Zhang, Tian
Guan, Xu-Wen
Gribben, John G.
Liu, Feng-Ting
Jia, Li
author Zhang, Tian
Guan, Xu-Wen
Gribben, John G.
Liu, Feng-Ting
Jia, Li
spellingShingle Zhang, Tian
Guan, Xu-Wen
Gribben, John G.
Liu, Feng-Ting
Jia, Li
Cell Death & Disease
Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma
Cancer Research
Cell Biology
Cellular and Molecular Neuroscience
Immunology
author_sort zhang, tian
spelling Zhang, Tian Guan, Xu-Wen Gribben, John G. Liu, Feng-Ting Jia, Li 2041-4889 Springer Science and Business Media LLC Cancer Research Cell Biology Cellular and Molecular Neuroscience Immunology http://dx.doi.org/10.1038/s41419-019-1563-8 <jats:title>Abstract</jats:title><jats:p>High mobility group box 1 (HMGB1) protein in the tumor microenvironment actively contributes to tumor progression but its role in diffuse large B-cell lymphoma (DLBCL) is unknown. The aim of this study was to determine the mechanism by which HMGB1 promotes tumor growth in DLBCL and whether blockade of HMGB1 signaling pathway could inhibit tumorigenesis. We report that HMGB1 promotes proliferation of DLBCL cells by activation of AKT, extracellular signal-regulated kinases 1/2 (ERK1/2), signal transducer and activator of transcription 3 (STAT3) and SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase (Src). Ethyl pyruvate (EP), an anti-inflammatory agent, inhibits HMGB1 active release from DLBCL cells and significantly inhibited proliferation of DLBCL cells in vitro. Treatment with EP significantly prevented and inhibited tumor growth in vivo and prolonged DLBCL-bearing mice survival. EP significantly downregulated HMGB1 expression and phosphorylation of Src and ERK1/2 in mice lymphoma tissue. EP induced accumulation of the cell cycle inhibitor p27 but downregulated expression of cyclin-dependent kinase 2 (CDK2). Increased nuclear translocation of p27 interacted with CDK2 and cyclin A, which led to blockade of cell cycle progression at the G1 to S phase transition. In conclusion, we demonstrated for the first time that blockade of HMGB1-mediated signaling pathway by EP effectively inhibited DLBCL tumorigenesis and disease progression.</jats:p> Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma Cell Death & Disease
doi_str_mv 10.1038/s41419-019-1563-8
facet_avail Online
Free
finc_class_facet Biologie
Psychologie
Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zNDE0MTktMDE5LTE1NjMtOA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zNDE0MTktMDE5LTE1NjMtOA
institution DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
imprint Springer Science and Business Media LLC, 2019
imprint_str_mv Springer Science and Business Media LLC, 2019
issn 2041-4889
issn_str_mv 2041-4889
language English
mega_collection Springer Science and Business Media LLC (CrossRef)
match_str zhang2019blockadeofhmgb1signalingpathwaybyethylpyruvateinhibitstumorgrowthindiffuselargebcelllymphoma
publishDateSort 2019
publisher Springer Science and Business Media LLC
recordtype ai
record_format ai
series Cell Death & Disease
source_id 49
title Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma
title_unstemmed Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma
title_full Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma
title_fullStr Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma
title_full_unstemmed Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma
title_short Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma
title_sort blockade of hmgb1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large b-cell lymphoma
topic Cancer Research
Cell Biology
Cellular and Molecular Neuroscience
Immunology
url http://dx.doi.org/10.1038/s41419-019-1563-8
publishDate 2019
physical
description <jats:title>Abstract</jats:title><jats:p>High mobility group box 1 (HMGB1) protein in the tumor microenvironment actively contributes to tumor progression but its role in diffuse large B-cell lymphoma (DLBCL) is unknown. The aim of this study was to determine the mechanism by which HMGB1 promotes tumor growth in DLBCL and whether blockade of HMGB1 signaling pathway could inhibit tumorigenesis. We report that HMGB1 promotes proliferation of DLBCL cells by activation of AKT, extracellular signal-regulated kinases 1/2 (ERK1/2), signal transducer and activator of transcription 3 (STAT3) and SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase (Src). Ethyl pyruvate (EP), an anti-inflammatory agent, inhibits HMGB1 active release from DLBCL cells and significantly inhibited proliferation of DLBCL cells in vitro. Treatment with EP significantly prevented and inhibited tumor growth in vivo and prolonged DLBCL-bearing mice survival. EP significantly downregulated HMGB1 expression and phosphorylation of Src and ERK1/2 in mice lymphoma tissue. EP induced accumulation of the cell cycle inhibitor p27 but downregulated expression of cyclin-dependent kinase 2 (CDK2). Increased nuclear translocation of p27 interacted with CDK2 and cyclin A, which led to blockade of cell cycle progression at the G1 to S phase transition. In conclusion, we demonstrated for the first time that blockade of HMGB1-mediated signaling pathway by EP effectively inhibited DLBCL tumorigenesis and disease progression.</jats:p>
container_issue 5
container_start_page 0
container_title Cell Death & Disease
container_volume 10
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792334309755977734
geogr_code not assigned
last_indexed 2024-03-01T14:26:37.06Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Blockade+of+HMGB1+signaling+pathway+by+ethyl+pyruvate+inhibits+tumor+growth+in+diffuse+large+B-cell+lymphoma&rft.date=2019-04-15&genre=article&issn=2041-4889&volume=10&issue=5&jtitle=Cell+Death+%26+Disease&atitle=Blockade+of+HMGB1+signaling+pathway+by+ethyl+pyruvate+inhibits+tumor+growth+in+diffuse+large+B-cell+lymphoma&aulast=Jia&aufirst=Li&rft_id=info%3Adoi%2F10.1038%2Fs41419-019-1563-8&rft.language%5B0%5D=eng
SOLR
_version_ 1792334309755977734
author Zhang, Tian, Guan, Xu-Wen, Gribben, John G., Liu, Feng-Ting, Jia, Li
author_facet Zhang, Tian, Guan, Xu-Wen, Gribben, John G., Liu, Feng-Ting, Jia, Li, Zhang, Tian, Guan, Xu-Wen, Gribben, John G., Liu, Feng-Ting, Jia, Li
author_sort zhang, tian
container_issue 5
container_start_page 0
container_title Cell Death & Disease
container_volume 10
description <jats:title>Abstract</jats:title><jats:p>High mobility group box 1 (HMGB1) protein in the tumor microenvironment actively contributes to tumor progression but its role in diffuse large B-cell lymphoma (DLBCL) is unknown. The aim of this study was to determine the mechanism by which HMGB1 promotes tumor growth in DLBCL and whether blockade of HMGB1 signaling pathway could inhibit tumorigenesis. We report that HMGB1 promotes proliferation of DLBCL cells by activation of AKT, extracellular signal-regulated kinases 1/2 (ERK1/2), signal transducer and activator of transcription 3 (STAT3) and SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase (Src). Ethyl pyruvate (EP), an anti-inflammatory agent, inhibits HMGB1 active release from DLBCL cells and significantly inhibited proliferation of DLBCL cells in vitro. Treatment with EP significantly prevented and inhibited tumor growth in vivo and prolonged DLBCL-bearing mice survival. EP significantly downregulated HMGB1 expression and phosphorylation of Src and ERK1/2 in mice lymphoma tissue. EP induced accumulation of the cell cycle inhibitor p27 but downregulated expression of cyclin-dependent kinase 2 (CDK2). Increased nuclear translocation of p27 interacted with CDK2 and cyclin A, which led to blockade of cell cycle progression at the G1 to S phase transition. In conclusion, we demonstrated for the first time that blockade of HMGB1-mediated signaling pathway by EP effectively inhibited DLBCL tumorigenesis and disease progression.</jats:p>
doi_str_mv 10.1038/s41419-019-1563-8
facet_avail Online, Free
finc_class_facet Biologie, Psychologie, Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zNDE0MTktMDE5LTE1NjMtOA
imprint Springer Science and Business Media LLC, 2019
imprint_str_mv Springer Science and Business Media LLC, 2019
institution DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275
issn 2041-4889
issn_str_mv 2041-4889
language English
last_indexed 2024-03-01T14:26:37.06Z
match_str zhang2019blockadeofhmgb1signalingpathwaybyethylpyruvateinhibitstumorgrowthindiffuselargebcelllymphoma
mega_collection Springer Science and Business Media LLC (CrossRef)
physical
publishDate 2019
publishDateSort 2019
publisher Springer Science and Business Media LLC
record_format ai
recordtype ai
series Cell Death & Disease
source_id 49
spelling Zhang, Tian Guan, Xu-Wen Gribben, John G. Liu, Feng-Ting Jia, Li 2041-4889 Springer Science and Business Media LLC Cancer Research Cell Biology Cellular and Molecular Neuroscience Immunology http://dx.doi.org/10.1038/s41419-019-1563-8 <jats:title>Abstract</jats:title><jats:p>High mobility group box 1 (HMGB1) protein in the tumor microenvironment actively contributes to tumor progression but its role in diffuse large B-cell lymphoma (DLBCL) is unknown. The aim of this study was to determine the mechanism by which HMGB1 promotes tumor growth in DLBCL and whether blockade of HMGB1 signaling pathway could inhibit tumorigenesis. We report that HMGB1 promotes proliferation of DLBCL cells by activation of AKT, extracellular signal-regulated kinases 1/2 (ERK1/2), signal transducer and activator of transcription 3 (STAT3) and SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase (Src). Ethyl pyruvate (EP), an anti-inflammatory agent, inhibits HMGB1 active release from DLBCL cells and significantly inhibited proliferation of DLBCL cells in vitro. Treatment with EP significantly prevented and inhibited tumor growth in vivo and prolonged DLBCL-bearing mice survival. EP significantly downregulated HMGB1 expression and phosphorylation of Src and ERK1/2 in mice lymphoma tissue. EP induced accumulation of the cell cycle inhibitor p27 but downregulated expression of cyclin-dependent kinase 2 (CDK2). Increased nuclear translocation of p27 interacted with CDK2 and cyclin A, which led to blockade of cell cycle progression at the G1 to S phase transition. In conclusion, we demonstrated for the first time that blockade of HMGB1-mediated signaling pathway by EP effectively inhibited DLBCL tumorigenesis and disease progression.</jats:p> Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma Cell Death & Disease
spellingShingle Zhang, Tian, Guan, Xu-Wen, Gribben, John G., Liu, Feng-Ting, Jia, Li, Cell Death & Disease, Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma, Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, Immunology
title Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma
title_full Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma
title_fullStr Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma
title_full_unstemmed Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma
title_short Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma
title_sort blockade of hmgb1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large b-cell lymphoma
title_unstemmed Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma
topic Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, Immunology
url http://dx.doi.org/10.1038/s41419-019-1563-8